Patents by Inventor Jacob LEMIEUX

Jacob LEMIEUX has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220220546
    Abstract: Provided herein is a nucleic acid detection system comprising a detection CRISPR system having an effector protein and one or more guide RNAs each designed to bind to corresponding target molecules that are diagnostic for a tick-borne disease state; and an RNA-based masking construct. In some embodiments, the detection system of may comprise i) two or more CRISPR systems, each CRISPR system comprising an effector protein and a guide RNA designed to bind to a corresponding target molecule that is diagnostic for a tick-borne disease state; and ii) a set of detection constructs, each detection construct comprising a cutting motif sequence that is preferentially cut by one of the activated CRISPR effector proteins. Exemplary tick-borne detectable microbes include Babesia micron, Anaplasma phagocytophilum, and Borrelia miyamotoi.
    Type: Application
    Filed: March 13, 2020
    Publication date: July 14, 2022
    Inventors: Pardis SABETI, Jacob LEMIEUX, Anne PIANTADOSI, Erica NORMANDIN, Gordon ADAMS, Eric ROSENBERG